
Ronibro-LM Tablet SR
Marketer
Ronish Bioceuticals
Salt Composition
Montelukast (10mg) + Levocetirizine (5mg) + Acebrophylline (200mg)
Overview Ronibro-LM Tablet SR
Lumiron SR tablets are prescribed to prevent asthma attacks. Their mechanism involves relaxing airway muscles, thereby expanding the airways and facilitating easier breathing. They also alleviate allergic symptoms including sneezing, nasal discharge, eye watering, itching, swelling, and skin rashes. Consistent daily dosing of Lumiron SR is recommended. If a dose is missed, take it immediately upon recollection. Avoid skipping doses and complete the entire treatment regimen, even with symptom improvement. Abrupt cessation of this medication should be avoided without prior consultation with a physician. Potential side effects include nausea, vomiting, diarrhea, and headache. Dizziness may occur; therefore, avoid driving or activities requiring alertness.
Uses of Ronibro-LM Tablet SR
Chronic respiratory condition
Major Benefits of Ronibro-LM Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ronibro-LM Tablet SR whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, however, consistent timing is recommended.
Common Side effects of Ronibro-LM Tablet SR:
- Nausea
- Vomiting
- Diarrhea
- Skin rash
- Flu-like symptoms
- Dryness in mouth
- Headache
- Fatigue
- Sleepiness
- Rash
- Hives
- Itching
- Breathing problems
- Increased white blood cell count
How to use Ronibro-LM Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not chew, crush, or divide it. Ronibro-LM Tablet SR can be administered with or without food, however, consistent timing is recommended.
How Ronibro-LM Tablet SR works:
Ronibro-LM SR tablets contain Montelukast, Levocetirizine, and Acebrophylline, working synergistically to alleviate allergy and respiratory symptoms. Montelukast, a leukotriene receptor antagonist, inhibits leukotriene activity, thereby diminishing airway and nasal inflammation and improving allergy symptoms. Levocetirizine, an antihistamine, targets allergic responses, relieving symptoms such as nasal discharge, lacrimation, and sneezing. Acebrophylline, a mucolytic agent, facilitates mucus clearance by reducing its viscosity, easing expectoration.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when drinking alcohol while taking Ronibro-LM Tablet SR. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Data on Ronibro-LM Tablet SR usage in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Ronibro-LM Tablet SR while breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Taking Ronibro-LM SR tablets may cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving is inadvisable if these effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Ronibro-LM Tablet SR. Dosage modification of Ronibro-LM Tablet SR might be necessary; physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Ronibro-LM Tablet SR cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Ronibro-LM Tablet SR :
Should you forget a dose of Ronibro-LM Tablet SR, take it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ronibro-LM Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Breathing |
